Drospirenone and non‐fatal venous thromboembolism: Is there a risk difference by dosage of Ethinyl‐Estradiol?

ConclusionsWe observed modestly elevated VTE risk with drospirenone, compared to levonorgestrel. The larger VTE incidence‐rate observed in DRSP/EE20 than DRSP/EE30, and the increasing VTE incidence‐rate with levonorgestrel between 2007‐2009 were unexpected.This article is protected by copyright. All rights reserved.

Source: Journal of Thrombosis and Haemostasis - April 11, 2013 Category: Hematology Authors: Steven T Bird, Joseph A C Delaney, Mahyar Etminan, James M Brophy, Abraham G Hartzema Tags: Original Article ‐ Clinical Haemostasis and Thrombosis Source Type: research